Leslie Dan Faculty of Pharmacy logo

 
MOLECULAR PHARMACOLOGY OF NEUROTRANSMITTER RECEPTORS

HomeResearchPublicationsGalleryHistory and ExtracurricularContact Us


Laboratory of David R. Hampson

Development of Gene Therapy for Autism Spectrum and other Neurodevelopmental Disorders

Professor, Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy,
and Department of Pharmacology & Toxicology, Faculty of Medicine.


David R. Hampson (Biographical Sketch)

David Hampson was born and raised in Rochester New York. He obtained his B.Sc. degree in biology from the State University of New York College of Environmental Science and Forestry at Syracuse, a M.Sc. degree in toxicology from Utah State University, and a Ph.D. degree in Pharmaceutical Sciences from the University of Alberta. He then did a Postdoctoral Fellowship at the Johns Hopkins University Dept. of Neurology in Baltimore and was subsequently a Staff Fellow at the National Institutes of Health in Bethesda, Maryland.


head schematics

Key words: autism, epilepsy, gene therapy, Fragile X Syndrome, Dravet Syndrome, seizures, viral vector, adeno-associated virus, biological therapeutics

 

Leslie Dan Faculty of Pharmacy Homepage | University of Toronto Homepage
Last updated: June 2021